Literature DB >> 10725807

Activation or destruction of T cells via macrophages.

T Orlikowsky1, G E Dannecker, Z Wang, H Horowitz, D Niethammer, M K Hoffmann.   

Abstract

Macrophages (MPhi) affect the T cell response in two mutually exclusive ways: activation or deletion. A MPhi type with T cell activating functions (M1) is able to express and upregulate receptors of the B7 family. IFN-gamma favours this MPhi differentiation pathway via upregulation of CD80 (B7-1) and CD86 (B7-2). The treatment of MPhi with IFN-gamma enhances the alphaCD3-mediated T cell blast transformation and reduces the fraction of deleted T cells. This MPhi type may prevent antibody-mediated T cell destruction by the expression of costimulatory receptors. An IL-10-induced MPhi type (M2) fails to express costimulatory molecules of the B7 family but is an effective cell for T cell destruction. Forming cellular conjugates with T cells through antibodies or immune complexes, M2-MPhi preferentially delete targeted cells in vitro and in vivo. Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10725807     DOI: 10.1159/000028084

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  3 in total

1.  Properties of human blood monocytes. II. Monocytes from healthy adults are highly heterogeneous within and among individuals.

Authors:  Dorothy Hudig; Kenneth W Hunter; W John Diamond; Doug Redelman
Journal:  Cytometry B Clin Cytom       Date:  2013-12-10       Impact factor: 3.058

2.  Matrix metalloproteases as maestros for the dual role of LPS- and IL-10-stimulated macrophages in cancer cell behaviour.

Authors:  Ana P Cardoso; Marta L Pinto; Ana T Pinto; Marta T Pinto; Cátia Monteiro; Marta I Oliveira; Susana G Santos; João B Relvas; Raquel Seruca; Alberto Mantovani; Marc Mareel; Mário A Barbosa; Maria J Oliveira
Journal:  BMC Cancer       Date:  2015-06-05       Impact factor: 4.430

Review 3.  Mechanisms of tumor resistance to immune checkpoint blockade and combination strategies to overcome resistance.

Authors:  Xiaoting Zhou; Yanghong Ni; Xiao Liang; Yi Lin; Biao An; Xiang He; Xia Zhao
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.